3-[3-(2-CYANO-4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE
Compound with spectra: 1 NMR
![3-[3-(2-CYANO-4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE](/api/compound/7AdbMcDu1GX.png?ph=true&h=300&w=458 "3-[3-(2-CYANO-4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE")
| SpectraBase Compound ID | 7AdbMcDu1GX |
|---|---|
| InChI | InChI=1S/C26H20FN5O2/c1-2-32-22-6-4-3-5-20(22)21-14-18(8-10-23(21)32)29-24(33)11-12-25-30-26(31-34-25)19-9-7-17(27)13-16(19)15-28/h3-10,13-14H,2,11-12H2,1H3,(H,29,33) |
| InChIKey | NVSKXWGRIBCWNF-UHFFFAOYSA-N |
| Mol Weight | 453.48 g/mol |
| Molecular Formula | C26H20FN5O2 |
| Exact Mass | 453.160103 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3:CD3OD=1:1 |
3-[3-(2-BROMO-4-FLUOROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE
3-[3-(2-FLUORO-4-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]-N-(9-ETHYL-9H-CARBAZOL-3-YL)-PROPANAMIDE
2-{[4-allyl-5-(4-methylphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(9-ethyl-9H-carbazol-3-yl)acetamide
(2E)-2-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-3-[(9-ethyl-9H-carbazol-3-yl)amino]-2-propenenitrile
3-(N-(6-Chloro-2-methylquinolin-4-yl)amino)-9-ethyl-9H-carbazole
(2E)-3-[(9-ethyl-9H-carbazol-3-yl)amino]-2-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]-2-propenenitrile
(2E)-2-[4-(3,4-dimethylphenyl)-1,3-thiazol-2-yl]-3-[(9-ethyl-9H-carbazol-3-yl)amino]-2-propenenitrile
3-(N-(2,6-Dimethylquinolin-4-yl)amino)-9-ethyl-9H-carbazole
(2E)-3-[(9-ethyl-9H-carbazol-3-yl)amino]-2-[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]-2-propenenitrile
1-(9-ethylcarbazol-3-yl)-2,4,5-trimethylpyrrole-3-carboxaldehyde
| Title | Journal or Book | Year |
|---|---|---|
| Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation | Organic and Medicinal Chemistry Letters | 2012 |